UBS Group reiterated their buy rating on shares of ConvaTec Group (LON:CTEC) in a research report released on Friday, ThisIsMoney.Co.Uk reports.
Several other equities research analysts have also commented on the stock. Jefferies Financial Group upped their price target on shares of ConvaTec Group from GBX 220 ($2.89) to GBX 250 ($3.29) and gave the company a buy rating in a report on Tuesday, January 21st. Peel Hunt reaffirmed a buy rating on shares of ConvaTec Group in a report on Thursday, February 13th. Peel Hunt reaffirmed a buy rating and issued a GBX 280 ($3.68) price target on shares of ConvaTec Group in a report on Friday, October 25th. Barclays lowered their price target on shares of ConvaTec Group from GBX 185 ($2.43) to GBX 182 ($2.39) and set an equal weight rating on the stock in a report on Tuesday, February 18th. Finally, JPMorgan Chase & Co. reaffirmed an underweight rating and issued a GBX 168 ($2.21) price target on shares of ConvaTec Group in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company’s stock. ConvaTec Group presently has an average rating of Hold and a consensus target price of GBX 202.36 ($2.66).
Shares of CTEC opened at GBX 212.90 ($2.80) on Friday. The firm has a market capitalization of $4.22 billion and a PE ratio of 26.61. The company has a debt-to-equity ratio of 104.76, a quick ratio of 1.58 and a current ratio of 2.37. ConvaTec Group has a 52-week low of GBX 127.45 ($1.68) and a 52-week high of GBX 225.80 ($2.97). The stock has a 50 day simple moving average of GBX 210.47 and a 200 day simple moving average of GBX 191.99.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Featured Story: What is a stock split?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.